WO2002008208A1 - Process for the preparation of optically active thiazolidinone derivatives - Google Patents

Process for the preparation of optically active thiazolidinone derivatives Download PDF

Info

Publication number
WO2002008208A1
WO2002008208A1 PCT/JP2001/004953 JP0104953W WO0208208A1 WO 2002008208 A1 WO2002008208 A1 WO 2002008208A1 JP 0104953 W JP0104953 W JP 0104953W WO 0208208 A1 WO0208208 A1 WO 0208208A1
Authority
WO
WIPO (PCT)
Prior art keywords
optically active
preparation
thiazolidinone derivatives
active thiazolidinone
carboxylic acid
Prior art date
Application number
PCT/JP2001/004953
Other languages
French (fr)
Japanese (ja)
Inventor
Tatsuya Kato
Tomokazu Ozaki
Kouichi Tsuzuki
Original Assignee
Chugai Seiyaku Kabushiki Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Seiyaku Kabushiki Kaisha filed Critical Chugai Seiyaku Kabushiki Kaisha
Priority to AU2001262746A priority Critical patent/AU2001262746A1/en
Publication of WO2002008208A1 publication Critical patent/WO2002008208A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/14Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A process for efficient synthesis of optically active thiazolidinone derivatives of the general formula (1) which comprises optically resolving a racemic carboxylic acid of the general formula (4) by using an (S)-(-)-N-benzyl-α-phenylalkylamine as the reagent for optical resolution to thereby obtain the corresponding (S)-carboxylic acid.
PCT/JP2001/004953 2000-07-26 2001-06-12 Process for the preparation of optically active thiazolidinone derivatives WO2002008208A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001262746A AU2001262746A1 (en) 2000-07-26 2001-06-12 Process for the preparation of optically active thiazolidinone derivatives

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000225684A JP2004002206A (en) 2000-07-26 2000-07-26 Method for producing optically active thiazolidinone derivative
JP2000-225684 2000-07-26

Publications (1)

Publication Number Publication Date
WO2002008208A1 true WO2002008208A1 (en) 2002-01-31

Family

ID=18719420

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2001/004953 WO2002008208A1 (en) 2000-07-26 2001-06-12 Process for the preparation of optically active thiazolidinone derivatives

Country Status (3)

Country Link
JP (1) JP2004002206A (en)
AU (1) AU2001262746A1 (en)
WO (1) WO2002008208A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3120368A1 (en) * 2021-03-02 2022-09-09 Compagnie Generale Des Etablissements Michelin Monomers containing a 4-thiazolidinone unit and their polyamide, polyester and polyurethane polycondensates.

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2661827A1 (en) * 2006-08-23 2008-02-28 Allergan, Inc. Therapeutic substituted thiazolidinones, oxazolidinones, and related compounds

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0705816A1 (en) * 1993-06-23 1996-04-10 Chugai Seiyaku Kabushiki Kaisha Benzene derivative useful for ischemic diseases
EP0845454A1 (en) * 1996-12-02 1998-06-03 Ajinomoto Co., Inc. Method for the production of optically active cyclopropane derivatives
JPH1180149A (en) * 1997-09-11 1999-03-26 Kuraray Co Ltd Optical resolution of (+,-)-chromancarboxylic acid
JP2000119228A (en) * 1998-10-09 2000-04-25 Sumitomo Chem Co Ltd Production of optically active benzylamine

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0705816A1 (en) * 1993-06-23 1996-04-10 Chugai Seiyaku Kabushiki Kaisha Benzene derivative useful for ischemic diseases
EP0845454A1 (en) * 1996-12-02 1998-06-03 Ajinomoto Co., Inc. Method for the production of optically active cyclopropane derivatives
JPH1180149A (en) * 1997-09-11 1999-03-26 Kuraray Co Ltd Optical resolution of (+,-)-chromancarboxylic acid
JP2000119228A (en) * 1998-10-09 2000-04-25 Sumitomo Chem Co Ltd Production of optically active benzylamine

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
KATO T. ET AL.: "Novel calcium antoganists with both calcium overload inhibition and antioxidant activity. 2. Structure-activity relationships of thiazolidinone derivatives", J. MED. CHEM., vol. 42, 1999, pages 3134 - 3146, XP002942300 *
KATO T. ET AL.: "Practical synthesis of novel cardioprotective drug, CP-060S", ORG. PROC. RES. AND DEV., vol. 5, no. 2, 2001, pages 122 - 126, XP002942401 *
MORRISON R.T. ET AL., TRANSLATION: K. NAKANISHI ET AL.: "Morrison boyd yuuki kagaku", 1995, TOKYO KAGAKU DOJIN, XP002942299 *
TIERZE L.F. ET AL., TRANSLATION: SEICHI KOUNO ET AL.: "Seimitsu yuuki kagaku 'Jikken manual'", 1995, NANKOUDOU, XP002942298 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3120368A1 (en) * 2021-03-02 2022-09-09 Compagnie Generale Des Etablissements Michelin Monomers containing a 4-thiazolidinone unit and their polyamide, polyester and polyurethane polycondensates.

Also Published As

Publication number Publication date
AU2001262746A1 (en) 2002-02-05
JP2004002206A (en) 2004-01-08

Similar Documents

Publication Publication Date Title
BG106786A (en) Process for the preparation of amorphous atorvastatin
DK0520406T3 (en) Diastereomeric salt of optically active quinoline mevalonic acid
EP1457487A4 (en) Process for production of optically active cis-piperidine derivatives
CA2432064A1 (en) Novel process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2r,4r)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide
DK0845464T3 (en) S-type 2-substituted hydroxy-2-indolidinyl butyric acid ester compounds as intermediates for camptothecin derivatives
CA2065008A1 (en) Light Activated Acyl-Enzymes
CA2272716A1 (en) Resolution of ritalinic acid salt
AU1289600A (en) Process for racemization
WO2002008208A1 (en) Process for the preparation of optically active thiazolidinone derivatives
NO20033917D0 (en) Process for the preparation of 2-azetidinone derivative
AU6117598A (en) Compounds
AU7002096A (en) Production of amide derivatives and intermediates therefor
PL326267A1 (en) Method of obtaining (1s,4r)- or (1r,4s)-4(2-amino-6-chloro-9h-purinyl-9)-cyclopentene-1-methanol
EP1571138A4 (en) Processes for producing (4e)-5-chloro-2-isopropyl-4-pentenoic ester and optically active isomer thereof
MXPA03011647A (en) Resolution process for (r)-(-)-2-hydroxy-2-(2-chlorophenyl) acetic acid.
DK0464488T3 (en) Optically active N-alpha-fluoroacryloylamino acid derivatives, their preparation, their optically active polymers prepared and their use for cleavage of racemates
WO2002059089A3 (en) Process for the preparation of heterocyclic indene analogs
MXPA01011104A (en) Process for synthesizing n-(mercaptoacyl) amino acid derivatives from alpha-substituted acrylic acids.
CA2320756A1 (en) Process for the production of optically enriched (r)- or (s)-albuterol
Senanayake et al. Rabbit liver esterase-mediated enantioselective synthesis of 2-arylpropanoic acids
IL108829A0 (en) Enzymatic resolution of alkyl 2-piperidinecarboxylates and use of the compounds obtained as synthesis intermediates
EP1340743A4 (en) Optically active amine derivative and method of synthesis
DE69809888T2 (en) Process for the preparation of alpha-aminoketones
EP1693364A4 (en) Intermediates for the production of optically active cyclopropylamine derivatives and process for the production of the intermediates
BR0013025A (en) Process for preparing acids via alpha-chloroeppoxy esters

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP